Letter to the Editor
International Journal of Impotence Research (2006) 18, 411. doi:10.1038/sj.ijir.3901451
Response to Tomsak, R. PDE5 inhibitors and permanent visual loss (Int J Impot Res 2005; 17: 547–549)
S J Watt1, P Primatesta1 and R Siegel2
- 1Pfizer Ltd, Kent, UK
- 2Pfizer Pharmaceuticals Group, New York, NY, USA
Correspondence: S J Watt, E-mail: Stephen.Watt@Pfizer.com
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Estrogen receptor β expression in vascular neoplasia: an analysis of 53 benign and malignant cases
Modern Pathology Original Article
International Journal of Impotence Research Letter
